<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>Financial Trader Research</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/" />
    <link rel="self" type="application/atom+xml" href="http://financialtrader.com/RSS/atom.xml" />
   <id>tag:financialtrader.com,2007:/RSS//2</id>
    <link rel="service.post" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2" title="Financial Trader Research" />
    <updated>2007-06-11T06:29:35Z</updated>
    <subtitle>Market Research, Analysis, and Commentary (Market Order out of Market Chaos © 2007)</subtitle>
    <generator uri="http://www.sixapart.com/movabletype/">Movable Type 3.2ysb5-20051201</generator>
 
<entry>
    <title>Interest Rate Forecast and Bonds Higher?</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/06/interest_rate_forecaste_and_bo.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=76" title="Interest Rate Forecast and Bonds Higher?" />
    <id>tag:financialtrader.com,2007:/RSS//2.76</id>
    
    <published>2007-06-11T06:27:29Z</published>
    <updated>2007-06-11T06:29:35Z</updated>
    
    <summary>Bonds have remained one of our core portfolio holdings since we  traded through the 5.00% level last year.  The question that needs answered is simple: will the recent downdraft in prices continue with 5.00% and above the new range, or is it simple panic selling?

More... http://www.financialtrader.com/Commentary/Market_Confluence6.11.07.html
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Commentary" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Bonds have remained one of our core portfolio holdings since we&nbsp; traded through the 5.00% level last year.&nbsp; The question that needs answered is simple: will the recent downdraft in prices continue with 5.00% and above the new range, or is it simple panic selling?</p><p>More... <a href="http://www.financialtrader.com/Commentary/Market_Confluence6.11.07.html">http://www.financialtrader.com/Commentary/Market_Confluence6.11.07.html</a></p><p>&nbsp;</p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/76/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/76/img/?url=http://financialtrader.com/RSS/2007/06/interest_rate_forecaste_and_bo.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Raising Sinovac’s 2007 First Half 2007 Revenue Forecast</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/05/raising_sinovacs_2007_first_ha.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=75" title="Raising Sinovac’s 2007 First Half 2007 Revenue Forecast" />
    <id>tag:financialtrader.com,2007:/RSS//2.75</id>
    
    <published>2007-05-31T14:21:48Z</published>
    <updated>2007-05-31T14:23:58Z</updated>
    
    <summary>Summary

We are raising our forecast of Sinovac’s first half 2007 revenues to $8.9mm from our February forecast of $7.8mm and are maintaining our current Earnings per Share (EPS) estimate of 2 cents/share. In this research report we are also commenting on several recent business developments and are reaffirming our current rating of Strong Speculative Buy.
 

Rationale:  Increasing Revenue Forecast

Sinovac recently reported unaudited first quarter revenue of $3.93 million which was higher than we were expecting. Historically, the first quarter of the year is Sinovac’s lowest revenue quarter. This is because of year end vaccine stockpiling by Sinovac’s customers as well as business disruption caused by the Chinese New Year holidays. Taking into consideration Sinovac’s exceptional first quarter revenue performance (up 134% vs. prior year) we believe it is appropriate to raise our first half revenue forecast.

After reviewing Sinovac’s audited full year 2006 financials, we have decided to raise our estimate of Sinovac’s Cost of Goods Sold and Operating Expenses for the first half of 2007. This is to take into consideration the higher level of forecasted revenue, higher level of start-up expenses associated with Sinovac’s launch of Anflu (seasonal flu vaccine) and higher level of administrative expenses (associated with Sarbanes Oxley compliance).  More
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Equity Research Reports" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Summary: &nbsp;We are raising our forecast of Sinovac&rsquo;s first half 2007 revenues to $8.9mm from our February forecast of $7.8mm and are maintaining our current Earnings per Share (EPS) estimate of 2 cents/share. In this research report we are also commenting on several recent business developments and are reaffirming our current rating of Strong Speculative Buy.</p><p>Rationale: Increasing Revenue Forecast Sinovac recently reported unaudited first quarter revenue of $3.93 million which was higher than we were expecting. Historically, the first quarter of the year is Sinovac&rsquo;s lowest revenue quarter. This is because of year end vaccine stockpiling by Sinovac&rsquo;s customers as well as business disruption caused by the Chinese New Year holidays. </p><p>Taking into consideration Sinovac&rsquo;s exceptional first quarter revenue performance (up 134% vs. prior year) we believe it is appropriate to raise our first half revenue forecast. After reviewing Sinovac&rsquo;s audited full year 2006 financials, we have decided to raise our estimate of Sinovac&rsquo;s Cost of Goods Sold and Operating Expenses for the first half of 2007. This is to take into consideration the higher level of forecasted revenue, higher level of start-up expenses associated with Sinovac&rsquo;s launch of Anflu (seasonal flu vaccine) and higher level of administrative expenses (associated with Sarbanes Oxley compliance). More... <a href="http://www.financialtrader.com/Investor_Contributed_Research/Sinovac_Research_Update5.31.2007.html">http://www.financialtrader.com/Investor_Contributed_Research/Sinovac_Research_Update5.31.2007.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/75/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/75/img/?url=http://financialtrader.com/RSS/2007/05/raising_sinovacs_2007_first_ha.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Bearish NASDAQ Portfolio Changes &amp; Research</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/05/bearish_nasdaq_portfolio_chang.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=74" title="Bearish NASDAQ Portfolio Changes &amp; Research" />
    <id>tag:financialtrader.com,2007:/RSS//2.74</id>
    
    <published>2007-05-20T14:01:18Z</published>
    <updated>2007-05-20T14:02:16Z</updated>
    
    <summary>Significant market developments prompt this update to the Financial Trader Research© master portfolio as of May 18th, 2007.  As we noted in our recent market note, the major indexes have surpassed the froth seen in the most roaring bull market of all time, and of course, things ended neither well, nor elegantly.  We do not believe that the current market will perform any differently, it&apos;s simply a matter of one single catalyst.  There are many possibilities such as another China based sell-off, interest rates breaching key support, or even the market falling under its own weight.  The catalyst is speculative, but the current vulnerable market conditions rest in historical fact rather than opinion. 

</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Equity Research Reports" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Significant market developments prompt this update to the Financial Trader Research&copy; master portfolio as of May 18th, 2007. As we noted in our recent market note, the major indexes have surpassed the froth seen in the most roaring bull market of all time, and of course, things ended neither well, nor elegantly. We do not believe that the current market will perform any differently, it's simply a matter of one single catalyst. </p><p>There are many possibilities such as another China based sell-off, interest rates breaching key support, or even the market falling under its own weight. The catalyst is speculative, but the current vulnerable market conditions rest in historical fact rather than opinion. </p><p>More... <a href="http://www.financialtrader.com/Master_Portfolio.html">http://www.financialtrader.com/Master_Portfolio.html</a></p><p>&nbsp;</p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/74/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/74/img/?url=http://financialtrader.com/RSS/2007/05/bearish_nasdaq_portfolio_chang.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>QQQQ &amp; SP500 Bearish Top and Sentiment</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/05/qqqq_sp500_bearish_top_and_sen.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=73" title="QQQQ &amp; SP500 Bearish Top and Sentiment" />
    <id>tag:financialtrader.com,2007:/RSS//2.73</id>
    
    <published>2007-05-18T11:11:02Z</published>
    <updated>2007-05-18T11:12:23Z</updated>
    
    <summary>Since our last update, the market has performed as expected printing new highs shortly after the Chinese driven stock sell off, (see here below).  But now the US macro market construct has deteriorated significantly.  

Welcome to tulip mania where the major US stock indexes are now trading in vertical fashion surpassing the frothiness of the great bull market in the late 1920&apos;s, which now looks tame by comparison.  But the &apos;new high&apos; headlines create commissions, profits, and stokes euphoria as though it were a religious experience, or better yet a Jimi Hendrix experience.  

Is the bull market supply of euphoria now over with last call being whispered in the din of the buying frenzy?
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Equity Research Reports" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Since our last update, the market has performed as expected printing new highs shortly after the Chinese driven stock sell off, (see here below). But now the US macro market construct has deteriorated significantly. Welcome to tulip mania where the major US stock indexes are now trading in vertical fashion surpassing the frothiness of the great bull market in the late 1920's, which now looks tame by comparison. </p><p>But the 'new high' headlines create commissions, profits, and stokes euphoria as though it were a religious experience, or better yet a Jimi Hendrix experience. Is the bull market supply of euphoria now over with last call being whispered in the din of the buying frenzy? </p><p>More... <a href="http://www.financialtrader.com/Stock_Buy_and_Sell_Opportunities.html">http://www.financialtrader.com/Stock_Buy_and_Sell_Opportunities.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/73/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/73/img/?url=http://financialtrader.com/RSS/2007/05/qqqq_sp500_bearish_top_and_sen.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Citigroup Buy Rating &amp; LLY Avoid Rating</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/04/citigroup_buy_rating_lly_sell.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=72" title="Citigroup Buy Rating &amp; LLY Avoid Rating" />
    <id>tag:financialtrader.com,2007:/RSS//2.72</id>
    
    <published>2007-04-16T07:44:03Z</published>
    <updated>2007-04-16T07:50:19Z</updated>
    
    <summary>Citigroup Fundamentals

There is a reason why every city&apos;s largest downtown buildings and skyscrapers are banks...they make money, and lots of it.   Citicorp (C) will report in line earnings today and continue to trade higher.  They are rated a solid buy based on solid fundamentals and their wonderful monopolistic business model.  

Currently, the stock yields over a 4.2% dividend, and has traded even with the S&amp;P500 over the past year if dividends are included, not a bad performance for a $250 billion market cap company.  

The recent job cuts were a move in the right direction, but not steep enough.  Investors need to see more outsourcing of operational staff to reduce overall costs.  It&apos;s clear that revenue will return to the entire banking sector once interest rates begin to decline anew.  </summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p><strong>Citigroup Fundamentals</strong> </p><p>There is a reason why every city's largest downtown buildings and skyscrapers are banks...they make money, and lots of it. Citicorp (C) will report in line earnings today and continue to trade higher. They are rated a solid buy based on solid fundamentals and their wonderful monopolistic business model. Currently, the stock yields over a 4.2% dividend, and has traded even with the S&amp;P500 over the past year if dividends are included, not a bad performance for a $250 billion market cap company. </p><p>The recent job cuts were a move in the right direction, but not steep enough. Investors need to see more outsourcing of operational staff to reduce overall costs. It's clear that revenue will return to the entire banking sector once interest rates begin to decline anew. </p><p><strong>Eli Lilly Stock Fundamentals</strong></p><p>As with most investors, I'm concerned about Eli Lilly's (LLY) stock performance over the past several quarters...dead money. The equity simply sits idle while many other large pharma's return at least market averages. LLY produces several psychiatric medicines and given today's crazy world its disappointing to see only a $77 billion market cap company. </p><p>The latest erectile dysfunction acquisition (Icos Corp) won't begin to hit the earnings book until 2008. The good news is that as companies such as Citigroup (above) continue to cut American staff and resources, the depression and erectile dysfunction market demand in the US should see a solid pick-up for LLY products and that holds hope for investors. </p><p>More...<a href="http://www.financialtrader.com/Ians_Cliff_Notes/Lilly_Citigroup_Stock_Note.html">http://www.financialtrader.com/Ians_Cliff_Notes/Lilly_Citigroup_Stock_Note.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/72/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/72/img/?url=http://financialtrader.com/RSS/2007/04/citigroup_buy_rating_lly_sell.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Crude Oil Bullish Forecast</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/04/crude_oil_bullish_forecast.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=71" title="Crude Oil Bullish Forecast" />
    <id>tag:financialtrader.com,2007:/RSS//2.71</id>
    
    <published>2007-04-02T10:32:22Z</published>
    <updated>2007-04-02T10:33:03Z</updated>
    
    <summary>Crude Oil Fundamental Analysis Brief

After tracking crude oil prices from the short side of the trade since August of last year, the models turned bullish last week with a close above our $62.00 stop based on the West Texas Intermediate cash market.  Despite the somewhat bearish supply and softer demand constructs, the price action simply overwhelmed even reasonable bearish arguments--if markets are ever reasonable.

The media bandied about the Iranians as the causal agent, but there is likely more under the surface than a story of a few hostages captured by a country that is renown in capturing western citizens, whether military or not.   China demand is probably the culprit for higher crude oil prices, but that is speculative for now.

</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Oil Trader" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Crude Oil Fundamental Analysis Brief </p><p>After tracking crude oil prices from the short side of the trade since August of last year, the models turned bullish last week with a close above our $62.00 stop based on the West Texas Intermediate cash market. Despite the somewhat bearish supply and softer demand constructs, the price action simply overwhelmed even reasonable bearish arguments--if markets are ever reasonable. </p><p>The media bandied about the Iranians as the causal agent, but there is likely more under the surface than a story of a few hostages captured by a country that is renown in capturing western citizens, whether military or not. China demand is probably the culprit for higher crude oil prices, but that is speculative for now. More... <a href="http://www.financialtrader.com/Oil_and_Energy_Trader/Crude_Oil_Bull_Market.4.2.2007.html">http://www.financialtrader.com/Oil_and_Energy_Trader/Crude_Oil_Bull_Market.4.2.2007.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/71/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/71/img/?url=http://financialtrader.com/RSS/2007/04/crude_oil_bullish_forecast.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Corn Still Bullish 4.2.2007</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/04/corn_srill_bullish_422007.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=70" title="Corn Still Bullish 4.2.2007" />
    <id>tag:financialtrader.com,2007:/RSS//2.70</id>
    
    <published>2007-04-02T09:00:26Z</published>
    <updated>2007-04-02T09:02:32Z</updated>
    
    <summary>Futures Update 4.2.2007

There has been little need to update this futures special, save for our brief instructions to the media:  prices have risen nearly vertical since we began our initial bullish forecast, in August of 2006.  But last week was different.  The grain markets sold off sharply on what was perceived to be a very bearish crop report, with plantings forecast to reach nearly 91 million acres.  

Obviously, the funds--net long futures contracts--were the original liquidators and primary culprits for the price chill.  From a fundamental perspective, the crop report managed to come in at the high end of expectations but still fell short of the number required to actually put the corn and grain complex bull market to rest.  After all, existing ethanol demand will lick up much of the typical carryover leaving ending stocks still near historic lows.

</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Futures Trader" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Corn Futures&nbsp;Forecast 4.2.2007 </p><p>There has been little need to update this futures special, save for our brief instructions to the media: prices have risen nearly vertical since we began our initial bullish forecast, in August of 2006. But last week was different. </p><p>The grain markets sold off sharply on what was perceived to be a very bearish crop report, with plantings forecast to reach nearly 91 million acres. Obviously, the funds--net long futures contracts--were the original liquidators and primary culprits for the price chill. From a fundamental perspective, the crop report managed to come in at the high end of expectations but still fell short of the number required to actually put the corn and grain complex bull market to rest. After all, existing ethanol demand will lick up much of the typical carryover leaving ending stocks still near historic lows. More...</p><p><a href="http://www.financialtrader.com/Futures_markets/Futures_Markets_Technicals.html">http://www.financialtrader.com/Futures_markets/Futures_Markets_Technicals.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/70/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/70/img/?url=http://financialtrader.com/RSS/2007/04/corn_srill_bullish_422007.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Master Investment Portfolio Commentary 3.30.2007</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/master_portfolio_commentary_33.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=69" title="Master Investment Portfolio Commentary 3.30.2007" />
    <id>tag:financialtrader.com,2007:/RSS//2.69</id>
    
    <published>2007-03-30T10:04:06Z</published>
    <updated>2007-03-30T10:06:35Z</updated>
    
    <summary>Its always a good sign when ones portfolio grows with few position changes, and as we expected at the beginning of the year, we had none for the first quarter of 2007, the same as the fourth quarter of last year.  The Financial Trader Master Portfolio grew a solid +3.6%, which easily surpassed the church mouse poor gains of the S&amp;P 500, up a meager +1.5% including dividends.  

Outperforming the S&amp;P is not always a difficult feat, but the startling facts reveal that the portfolio achieved this return with 75%  allocated to risk free government treasuries, and mostly avoided the free fall of early March.  If you sleep well, you&apos;ll profit well, we say.

</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Equity Research Reports" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Its always a good sign when ones portfolio grows with few position changes, and as we expected at the beginning of the year, we had none for the first quarter of 2007, the same as the fourth quarter of last year. The Financial Trader Master Portfolio grew a solid +3.6%, which easily surpassed the church mouse poor gains of the S&amp;P 500, up a meager +1.5% including dividends. </p><p>Outperforming the S&amp;P is not always a difficult feat, but the startling facts reveal that the portfolio achieved this return with 75% allocated to risk free government treasuries, and mostly avoided the free fall of early March. If you sleep well, you'll profit well, we say. </p><p>US Treasuries and Bonds Still a Buy </p><p>We believe that Treasuries remain safely positioned for the next quarter, but as we mentioned in earlier notes, some of the allocations will be rolled off into more promising stock positions in the very near future We have been bullish the bond market for several quarters now, and our fundamental and technical models continue to point to a softer economy, and lower interest rates. The capital markets speak louder than Fed rhetoric and unethical journalists that confuse news with gossip. See our original bond forecast here. </p><p>Speculative Stocks Growing Even Stronger </p><p>We have two speculative equities in our portfolio that performed very well for the quarter. Sinovac (SVA), our favorite Chinese stock, gained +23% and achieved a number of critical financial milestones. It is leaping down the path in what could be uber-profitability this year. As an added bonus, both its share price performance and management execution this quarter stirred growing institutional activity and accumulation. Pacific Ethanol, (PEIX) up +13%, despite the media and oil industry detractors, continues to execute in a turbulent energy environment and both stocks remain comfortably stashed in our portfolio well into the foreseeable future.&nbsp; More...</p><p><a href="http://www.financialtrader.com/Master_Portfolio.html">http://www.financialtrader.com/Master_Portfolio.html</a></p><p>The Euro and Corn, No Leverage Needed </p><p>The cash based Corn position grew by +1.5% and is one of our favorites for the summer quarter, which should surprise many with a near 50% gain in the commodity. We see no discernable weakness in either corn fundamental demand, technical market construct, or the futures markets, even though the paid-for- media continues to try to talk prices lower. The Euro FX cash deposit is our widow and orphan position designed to generate slightly higher returns than US Treasuries. The Euro returned +2.5% for the quarter and remains in our portfolio as well. </p><p>Where Do We Go From Here? A simple call for action, of course. Write or drop an entry on our anonymous blog if you are interested in the continued free Financial Trader Research Portfolios, Notes, and Reports. </p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/69/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/69/img/?url=http://financialtrader.com/RSS/2007/03/master_portfolio_commentary_33.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Sinovac&apos;s Institutional Ownership Growing (Bullish)</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/sinovacs_institutional_ownersh.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=68" title="Sinovac's Institutional Ownership Growing (Bullish)" />
    <id>tag:financialtrader.com,2007:/RSS//2.68</id>
    
    <published>2007-03-20T15:31:31Z</published>
    <updated>2007-03-20T15:32:45Z</updated>
    
    <summary>Although institutional holdings in Sinovac climbed in the latest reporting quarter, the investment by Sansar Capital Management dwarfs all other institutional holdings.  As shown in Table 1 below, combined institutional holdings in Sinovac stock totaled approximately 2.05 million shares at year end, 2006.  This was an increase of roughly 556,000 shares from the previous quarter. Thus, Sansar Capital Management’s position in Sinovac exceeds the combined holdings of all other institutional investors in the company. We view this as another indication of Sinovac’s investment attractiveness, and accordingly reaffirms our Strong Speculative Buy Rating on its stock.
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Equity Research Notes" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Although institutional holdings in Sinovac climbed in the latest reporting quarter, the investment by Sansar Capital Management dwarfs all other institutional holdings. As shown in Table 1 below, combined institutional holdings in Sinovac stock totaled approximately 2.05 million shares at year end, 2006. This was an increase of roughly 556,000 shares from the previous quarter. Thus, Sansar Capital Management&rsquo;s position in Sinovac exceeds the combined holdings of all other institutional investors in the company. We view this as another indication of Sinovac&rsquo;s investment attractiveness, and accordingly reaffirms our Strong Speculative Buy Rating on its stock. </p><p>&nbsp;</p><p>Sansar Capital Sansar Capital is a New York City based pan-Asian long/short fund launched in 2005 by Sanjay Motwani, who previously managed investments at the highly respected Kingdon Capital, an investment management firm. In addition, he also worked as a research analyst at Fidelity, Lehman Brothers, and Chase. In July 2005, Sansar Capital filed a 13G for a similar large position in Taiwan headquartered Gigamedia Ltd., when the stock was trading roughly 75% lower than current prices and continues to hold a sizeable position in the stock. In other words, Sansar appears to be a high quality investor, with a track record of success, particularly with small capitalization stocks.&nbsp;&nbsp; More... <a href="http://www.financialtrader.com/Sinovac/Sinovac_Research_Update3.20.2007.html">http://www.financialtrader.com/Sinovac/Sinovac_Research_Update3.20.2007.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/68/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/68/img/?url=http://financialtrader.com/RSS/2007/03/sinovacs_institutional_ownersh.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>NASDAQ &amp; S&amp;P Market Update 3.19.2007</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/nasdaq_sp_market_update_319200.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=67" title="NASDAQ &amp; S&amp;P Market Update 3.19.2007" />
    <id>tag:financialtrader.com,2007:/RSS//2.67</id>
    
    <published>2007-03-19T01:55:19Z</published>
    <updated>2007-03-19T01:56:11Z</updated>
    
    <summary>Since our last report, March 6th, not much as changed in the equity markets.  As we expected, the markets continued to probe for buying support and made a slightly lower print over the past week where the market experienced some enthusiastic buying.  There remains a probability that the market might stab an additional 3% to 4% lower to complete a short term correction of roughly -8% in the S&amp;P500 or -10% in the NASDAQ.  

But sentiment, a contrary indicator, continues to support a more immediate bullish scenario.  As we noted earlier, from a fundamental perspective, the yield curve has greatly improved during the sell-off and this continues to have a mitigating effect on lower stock prices.  The mortgage market collapse continues its role as the primary agent, and we expect the fall out to be constructive for bonds and treasuries, which is where more than half of our master model portfolio positions currently live.  

In addition, stronger Asian economies such as China are deliberately choking growth with higher rates.  A trend that will impact US growth rates sooner rather than later, and reinforce the multi-decade freefall of the US Dollar.  
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Recently Published Articles" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Since our last report, March 6th, not much as changed in the equity markets. As we expected, the markets continued to probe for buying support and made a slightly lower print over the past week where the market experienced some enthusiastic buying. There remains a probability that the market might stab an additional 3% to 4% lower to complete a short term correction of roughly -8% in the S&amp;P500 or -10% in the NASDAQ. </p><p>But sentiment, a contrary indicator, continues to support a more immediate bullish scenario. As we noted earlier, from a fundamental perspective, the yield curve has greatly improved during the sell-off and this continues to have a mitigating effect on lower stock prices. The mortgage market collapse continues its role as the primary agent, and we expect the fall out to be constructive for bonds and treasuries, which is where more than half of our master model portfolio positions currently live. In addition, stronger Asian economies such as China are deliberately choking growth with higher rates. A trend that will impact US growth rates sooner rather than later, and reinforce the multi-decade freefall of the US Dollar. </p><p>More...&nbsp; <a href="http://www.financialtrader.com/Stock_Buy_and_Sell_Opportunities.html">http://www.financialtrader.com/Stock_Buy_and_Sell_Opportunities.html</a>&nbsp;</p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/67/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/67/img/?url=http://financialtrader.com/RSS/2007/03/nasdaq_sp_market_update_319200.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Google Buy Signal Bullish For Market</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/google_buy_signal_bullish_for.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=66" title="Google Buy Signal Bullish For Market" />
    <id>tag:financialtrader.com,2007:/RSS//2.66</id>
    
    <published>2007-03-14T05:33:56Z</published>
    <updated>2007-03-14T05:38:24Z</updated>
    
    <summary>Google Analysis Brief

We last visited Google a few weeks back detailing that without a Google push higher, the market was brewing lower prices ahead and due for a  near term, steep sell-off.  March growled as a bear rather than a lion and proved that forecast eerily accurate.  

The good news now reveals that Google has formed a meaningful trading bottom and with strong fundamentals (the best in the industry) Google should support the entire market as the current correction begins to fade.   

What About the Recent Publishing Law Suits

The restive publishing industry remains panicked by lack of content control and an industry in historic flux.  A nearly 500 year monopoly (think early printing press) has been summarily dispatched and left to the hands of the unlearned social media sites. 
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Commentary" />
            <category term="Equity Research Notes" />
            <category term="Recently Published Articles" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Google Analysis Brief:</p><p>We last visited Google a few weeks back detailing that without a Google push higher, the market was brewing lower prices ahead and due for a near term, steep sell-off. March growled as a bear rather than a lion and proved that forecast eerily accurate. </p><p>The good news now reveals that Google has formed a meaningful trading bottom and with strong fundamentals (the best in the industry) Google should support the entire market as the current correction begins to fade. What About the Recent Publishing Law Suits The restive publishing industry remains panicked by lack of content control and an industry in historic flux. A nearly 500 year monopoly (think early printing press) has been summarily dispatched and left to the hands of the unlearned social media sites. </p><p>More... <a href="http://www.financialtrader.com/Commentary/Goog_Buy_And_Analysis.html">http://www.financialtrader.com/Commentary/Goog_Buy_And_Analysis.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/66/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/66/img/?url=http://financialtrader.com/RSS/2007/03/google_buy_signal_bullish_for.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Halliburton Runs Out Of Dodge, Rates A Sell</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/halliburton_runs_out_of_dodge.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=65" title="Halliburton Runs Out Of Dodge, Rates A Sell" />
    <id>tag:financialtrader.com,2007:/RSS//2.65</id>
    
    <published>2007-03-13T09:07:08Z</published>
    <updated>2007-03-13T23:34:40Z</updated>
    
    <summary>Halliburton moves to the Middle East in the modern sequel to Ali Baba and the 40 thieves.  No doubt, the move provided ample fodder for the politicians, but from the investor&apos;s perspective what does it really mean?

Historically, the multinational corporation was always considered borderless and country-less, so from a purely operational viewpoint the move means little. 

For the historically challenged, multinationals were viewed with suspicion by the some of the founding fathers as &apos;traitors in waiting&apos;.  However, from a strategic standpoint, it is clear that big oil and oil services have more friends in the oil producing nations than in the U.S., where the momentum to go green is now inexorable and the most significant economic construct of the decade.

Readers know that we have been bearish the crude complex and several large cap oil stocks based (in part)  on this underlying trend.  Halliburton&apos;s move is risky from the public relations perspective, but from a business vantage, the company needs to position itself in a growth market, which is one of the  ostensible reasons for the move. 
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Oil Trader" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p align="left"><strong>Halliburton</strong><strong> Analysis Brief</strong></p><p align="left">Halliburton moves to the Middle East in the modern sequel to Ali Baba and the 40 thieves.&nbsp; No doubt, the move provided ample fodder for the politicians, but from the investor's perspective what does it really mean?</p><p align="left">Historically, the multinational corporation was always considered borderless and country-less, so from a purely operational viewpoint the move means little. </p><p align="left">For the historically challenged, multinationals were viewed with suspicion by some of the founding fathers as 'traitors in waiting'.&nbsp; However, from a strategic standpoint, it is clear that big oil and oil services have more friends in the oil producing nations than in the U.S., where the momentum to go green is now inexorable and the most significant economic construct of the decade.</p><p align="left">Readers know that we have been <a href="http://www.financialtrader.com/Oil_and_Energy_Trader/Oil_Bear_Market1.17.2006.html">bearish the crude complex</a> and several large cap oil stocks based (in part)&nbsp; on this underlying trend.&nbsp; Halliburton's move is risky from the public relations perspective, but from a business vantage, the company needs to position itself in a growth market, which is one of the&nbsp; ostensible reasons for the move. More... <a href="http://financialtrader.com/Commentary/HAL_Sell_And_Analysis.html">http://financialtrader.com/Commentary/HAL_Sell_And_Analysis.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/65/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/65/img/?url=http://financialtrader.com/RSS/2007/03/halliburton_runs_out_of_dodge.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Syneron Buy Rating, Analysis, and Forecast</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/syneron_buy_rating_analysis_an.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=64" title="Syneron Buy Rating, Analysis, and Forecast" />
    <id>tag:financialtrader.com,2007:/RSS//2.64</id>
    
    <published>2007-03-11T03:16:33Z</published>
    <updated>2007-03-11T03:19:50Z</updated>
    
    <summary>Fundamental Analysis Brief

We rated Syneron Medical a buy based on several positive fundamental and technical constructs, which  includes our patent pending Lupo-Kioutas© enterprise business model. 

Syneron first showed up on our buy radar over one year ago when they transparently announced no forward earnings guidance based on a lack of visibility, and other logical business reasons.  It is indeed rare for any publicly traded firm to practice such transparency, which is key to our enterprise business model, yet management was rewarded with a rapid share price reduction from $40 to sub $20 pricing:  vintage, myopic Wall Street. 
</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Equity Research Notes" />
            <category term="Equity Research Reports" />
            <category term="Recently Published Articles" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Fundamental Analysis Brief We rated Syneron Medical a buy based on several positive fundamental and technical constructs, which includes our patent pending Lupo-Kioutas&copy; enterprise business model.&nbsp; </p><p>Syneron first showed up on our buy radar over one year ago when they transparently announced no forward earnings guidance based on a lack of visibility, and other logical business reasons. It is indeed rare for any publicly traded firm to practice such transparency, which is key to our enterprise business model, yet management was rewarded with a rapid share price reduction from $40 to sub $20 pricing: vintage, myopic Wall Street.&nbsp; More... <a href="http://www.financialtrader.com/ELOS_Mini-Re/ELOS_Buy_And_Analysis.html">http://www.financialtrader.com/ELOS_Mini-Re/ELOS_Buy_And_Analysis.html</a></p><p>&nbsp;</p><p>&nbsp;</p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/64/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/64/img/?url=http://financialtrader.com/RSS/2007/03/syneron_buy_rating_analysis_an.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>MindRay Buy Rating, Analysis, and Forecast</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/mindray_buy_rating_analysis_an.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=63" title="MindRay Buy Rating, Analysis, and Forecast" />
    <id>tag:financialtrader.com,2007:/RSS//2.63</id>
    
    <published>2007-03-08T07:38:06Z</published>
    <updated>2007-03-08T07:40:04Z</updated>
    
    <summary>Fundamental Analysis Brief:

We rated MindRay Medical a buy based on several positive fundamental and technical constructs which  includes our patent pending Lupo-Kioutas© enterprise business model.  In addition, the equity has received support from a less than talented financial media.

The Media is Full Of Amateurs

While the media is quick to point out a recent 120% gain in China&apos;s Shanghai index, most fail to mention that over the past six years the index gained only slightly more than 30%.  Hardly a runaway bull market, and nowhere near the tulip market levels achieved in 2001 right here in the U.S.  We find that the recent decline in the index has provided some excellent entry points for a number of solid Chinese business models, including MR.  

</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Equity Research Notes" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p>Fundamental Analysis Brief: We rated MindRay Medical a buy based on several positive fundamental and technical constructs which includes our patent pending Lupo-Kioutas� enterprise business model. In addition, the equity has received support from a less than talented financial media. </p><p>The Media is Full Of Amateurs </p><p>While the media is quick to point out a recent 120% gain in China's Shanghai index, most fail to mention that over the past six years the index gained only slightly more than 30%. Hardly a runaway bull market, and nowhere near the tulip market levels achieved in 2001 right here in the U.S. We find that the recent decline in the index has provided some excellent entry points for a number of solid Chinese business models, including MR. </p><p>More... <a href="http://www.financialtrader.com/MR_Mini-Re/MR_Buy_And_Analysis.html">http://www.financialtrader.com/MR_Mini-Re/MR_Buy_And_Analysis.html</a></p><p>&nbsp;</p><p>&nbsp;</p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/63/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/63/img/?url=http://financialtrader.com/RSS/2007/03/mindray_buy_rating_analysis_an.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>
<entry>
    <title>Stock Market Bottom in Place? 3.6.2007</title>
    <link rel="alternate" type="text/html" href="http://financialtrader.com/RSS/2007/03/stock_market_bottom_in_place_3.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://financialtrader.com/blog-mt/mt-atom.cgi/weblog/blog_id=2/entry_id=62" title="Stock Market Bottom in Place? 3.6.2007" />
    <id>tag:financialtrader.com,2007:/RSS//2.62</id>
    
    <published>2007-03-05T22:45:40Z</published>
    <updated>2007-03-05T23:14:45Z</updated>
    
    <summary>NASDAQ &amp; S&amp;P Market Update 3.6.2007 

Corrections and bear markets do have one redeeming quality, they usually stay around no longer than a disloyal friend.  And that is a good thing for it reveals how many investor friends your stocks actually possess.  Friends you say, &apos;my stocks are outright lepers in this environment&apos;.  But there is good news...

The market has sold off so quickly and with such fear that our sentiment models now throttle near bullish, after reading negative for weeks.  In addition, our initial support objectives in the SPX and the NASDAQ were met this Monday, 3.6.2007, on the close of trade. 

From a fundamental perspective, the yield curve has greatly improved during the speedy sell-off and this will have a mitigating effect on lower stock prices.  At the very least, our WatlooSoft© models are currently flashing a trading bottom, which is positive when bundled with the sentiment figures.

</summary>
    <author>
        <name>LM Lupo</name>
        <uri>www.financialtrader.com</uri>
    </author>
            <category term="Recently Published Articles" />
    
    <content type="html" xml:lang="en" xml:base="http://financialtrader.com/RSS/">
        <![CDATA[<p style="margin-bottom: 0in"><strong>NASDAQ &amp; S&amp;P Market Update 3.6.2007 </strong></p><p style="margin-bottom: 0in">Corrections and bear markets do have one redeeming quality, they usually stay around no longer than a disloyal friend.&nbsp; And that is a good thing for it reveals how many investor friends your stocks actually possess.&nbsp; Friends you say, 'my stocks are outright lepers in this environment'.&nbsp; But there is good news...</p><p style="margin-bottom: 0in">The market has sold off so quickly and with such fear that our sentiment models now throttle near bullish, after reading negative for weeks.&nbsp; In addition, our <a href="http://www.financialtrader.com/Stock_Trader/Nasdaq_Note_1.22.2007.html">initial support objectives</a> in the SPX and the NASDAQ were met this Monday, 3.6.2007, on the close of trade. </p><p style="margin-bottom: 0in">From a <a href="http://financialtrader.com/Stock_Trader/Index_Sell_Signals.html">fundamental perspective</a>, the yield curve has greatly improved during the speedy sell-off and this will have a mitigating effect on lower stock prices.&nbsp; At the very least, our WatlooSoft&copy; models are currently flashing a trading bottom, which is positive when bundled with the sentiment figures.</p><p>The mortgage meltdown from the housing market gluttony of the past few years stands as the primary fundamental negative. Not to worry though, the feds will certainly smash rates soon to soothe frayed nerves and avoid an outright $600 billion dollar mortgage market collapse, just like they did with Long Term Capital. But, as we noted earlier in our bond report, the fed is a bit behind the curve here; nevertheless, they will catch up, and make Alexander Hamilton proud. </p><p>More.. <a href="http://www.financialtrader.com/Stock_Trader/Stock_Buy_Opportunity_3.6.2007.html">http://www.financialtrader.com/Stock_Trader/Stock_Buy_Opportunity_3.6.2007.html</a></p>]]>
        
<![CDATA[<!-- begin(Yahoo ad) --><a href="http://ypn-rss.overture.com/rss/34698/62/click/"><img 

src="http://ypn-rss.overture.com/rss/34698/62/img/?url=http://financialtrader.com/RSS/2007/03/stock_market_bottom_in_place_3.html&amp;pid=1525743100" 

alt="Ads by Yahoo!" border="0"/></a><!-- end(Yahoo ad) -->]]>
    </content>
</entry>

</feed> 

